Money News With Ross Greenwood: Highlights

Leslie Chong, Imugene CEO

Informações:

Synopsis

Imugene will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded more ‘complete responses’ in its phase 1b study.See omnystudio.com/listener for privacy information.